Point72 Asset Management
NGNE icon

Point72 Asset Management’s Neurogene NGNE Stock Holding History

Point72 Asset Management’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,669
Closed -$133K – 4079
2025
Q3 		$133K Buy
+7,669
New +$154K ﹤0.01% 2185
2024
Q2 		– Sell
-28,033
Closed -$1.43M – 2260
2024
Q1 		$1.43M Buy
+28,033
New +$936K ﹤0.01% 1376
2023
Q4 		– Sell
-6,834
Closed -$108K – 2592
2023
Q3 		$108K Hold
6,834
– – ﹤0.01% 1949
2023
Q2 		$113K Hold
6,834
– – ﹤0.01% 1515
2023
Q1 		$95.7K Hold
6,834
– – ﹤0.01% 1640
2022
Q4 		$69.6K Sell
6,834
-96,377
-93% -$995K ﹤0.01% 1324
2022
Q3 		$1.32M Buy
103,211
+31,340
+44% +$640K 0.01% 1011
2022
Q2 		$1.48M Buy
71,871
+10,621
+17% +$259K 0.01% 1002
2022
Q1 		$2.3M Buy
61,250
+10,710
+21% +$625K 0.01% 855
2021
Q4 		$4.87M Buy
50,540
+540
+1% +$65.8K 0.02% 682
2021
Q3 		$7.23M Buy
50,000
+5,845
+13% +$895K 0.03% 569
2021
Q2 		$8.15M Sell
44,155
-21,275
-33% -$4.71M 0.04% 500
2021
Q1 		$16.1M Buy
65,430
+5,644
+9% +$1.44M 0.08% 314
2020
Q4 		$16.9M Buy
59,786
+9,801
+20% +$2.39M 0.08% 316
2020
Q3 		$12M Buy
49,985
+25,435
+104% +$6.16M 0.06% 374
2020
Q2 		$8.15M Sell
24,550
-5,510
-18% -$1.44M 0.05% 384
2020
Q1 		$6.84M Buy
30,060
+23,721
+374% +$4.88M 0.06% 349
2019
Q4 		$1.56M Buy
+6,339
New +$631K 0.01% 653
2018
Q2 		– Sell
-12,505
Closed -$3.52M – 1117
2018
Q1 		$3.52M Sell
12,505
-3,750
-23% -$1.04M 0.01% 649
2017
Q4 		$3.82M Buy
+16,255
New +$3.81M 0.02% 640

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management's NGNE Position: Q4 2025 in Review

Point72 Asset Management sold out of Neurogene (NGNE) in Q4 2025, closing a stake of 7,669 shares — an estimated $133K sold.

Point72 Asset Management first reported a position in NGNE in Q4 2017 and held it in 20 quarters. The position peaked at $16.9M in Q4 2020. 93 funds tracked by Wall St. Rank hold NGNE as of Q4 2025.

  • Point72 Asset Management reported no remaining Neurogene position as of Q4 2025 after selling out during the quarter.
  • Point72 Asset Management sold 7,669 Neurogene shares in Q4 2025, an estimated $133K.
  • Point72 Asset Management first reported a position in Neurogene in Q4 2017 and held it in 20 quarters.
  • Point72 Asset Management's Neurogene position peaked at $16.9M in Q4 2020.
  • 93 funds tracked by Wall St. Rank held Neurogene as of Q4 2025.

Based on Point72 Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.